Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference - WMBB News 13 - The Panhandle's News Leader

Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference

  • What's Going Around

  • Wednesday, May 15 2013 11:45 AM EDT2013-05-15 15:45:20 GMT
    While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week. What is pneumonia? Pneumonia
    While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week.

  • Wednesday, May 8 2013 9:06 AM EDT2013-05-08 13:06:30 GMT
    We all have our aches in our bellies and backs from time to time, but these pains can also be signs of gallstones. Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are
    Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are what's going around.

  • Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.
    •   

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Innophos Holdings, Inc.

CRANBURY, N.J., March 7, 2013 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: "IPHS") today announced that Neil Salmon, Chief Financial Officer, will address the 2013 Sidoti Emerging Growth Institutional Investor Forum, in New York City, on March 18, 2013.  The event will not be webcast.  Presentation slides will be available on the morning of March 18th on the Innophos website, www.innophos.com, in the Investor Relations Events section.

About Innophos Holdings, Inc.
Innophos is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets.  Innophos combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other specialty ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide.  Innophos is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service.  Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Ogden, UT; North Salt Lake, UT; Paterson, NJ; Green Pond, SC; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please visit www.innophos.com. 'IPHS-G'IPHS-G'

Contact Information:

Innophos Holdings, Inc.

FTI Consulting, Inc.

Investor Relations: (609) 366-1299

Bryan Armstrong/Matt Steinberg

investor.relations@innophos.com 

(212) 850-5600

©2012 PR Newswire. All Rights Reserved.